頭頸椎癌症治療藥的全球市場,各類型,各治療類型,各終端用戶,各地區,企業,機會及預測,2027年
市場調查報告書
商品編碼
1068574

頭頸椎癌症治療藥的全球市場,各類型,各治療類型,各終端用戶,各地區,企業,機會及預測,2027年

Global Head and Neck Cancer Therapeutics Market, By Type, By Treatment Type, By End User, By Region, Company, Opportunities and Forecast, 2027

出版日期: | 出版商: TechSci Research | 英文 358 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

全球頭頸椎癌症治療藥的市場規模,2021年是20億2,433萬美金。

該市場,在預測期間的2023年~2027年預計以7.22%的年複合成長率擴大,2027年達到31億2,626萬美元。這樣驚人成長的背景,有醫療保健產業,尤其是癌症治療的發展。頭部癌症和咽喉癌等癌症的案例持續增加,更加推動今後5年的全球頭頸椎癌症治療藥市場成長。

本報告提供全球頭頸椎癌症治療藥市場相關調查,市場概要,以及各類型,各治療類型,各終端用戶,各地區的趨勢,競爭趨勢,及加入此市場的主要企業簡介等資訊。

目錄

第1章 產品概要

第2章 調查手法

第3章 摘要整理

第4章 客戶的迴響

第5章 全球頭頸椎癌症治療藥市場預測

  • 市場規模與預測
  • 市場佔有率與預測
    • 各類型(診斷方法對治療類型)
    • 各地區
    • 各企業(2021年)
  • 產品市場地圖

第6章 北美的頭頸椎癌症治療藥市場預測

  • 市場規模與預測
  • 市場佔有率與預測
  • 北美:各國分析

第7章 歐洲的頭頸椎癌症治療藥市場預測

  • 市場規模與預測
  • 市場佔有率與預測
  • 歐洲:各國分析

第8章 亞太地區的頭頸椎癌症治療藥市場預測

  • 市場規模與預測
  • 市場佔有率與預測
  • 亞太地區:各國分析

第9章 南美的頭頸椎癌症治療藥市場預測

  • 市場規模與預測
  • 市場佔有率與預測
  • 南美:各國分析

第10章 中東、非洲的頭頸椎癌症治療藥市場預測

  • 市場規模與預測
  • 市場佔有率與預測
  • 中東、非洲:各國分析

第11章 臨床試驗分析

第12章 COVID-19對全球頭頸椎癌症治療藥市場的影響

第13章 市場動態

  • 促進因素
  • 課題

第14章 市場趨勢與發展

第15章 競爭情形

  • 競爭預測
  • 主要企業簡介
    • Eli Lilly and Company
    • Bristol Myers Squibb Company
    • Sanofi S.A.
    • Merck & Co., Inc.
    • Pfizer Inc
    • AbbVie Inc.
    • Bayer AG
    • F. Hoffmann-La Roche Ltd.
    • Fresenius Medical Care AG & Co. KGaA
    • Sun Pharmaceutical Industries Ltd.
    • Teva Pharmaceutical Industries Limited
    • AstraZeneca Plc.
    • Astellas Pharma Inc.
    • AB Science SA
    • Boston Biomedical, Inc.

第16章 策略性推薦事項

Product Code: 5056

Global head and neck cancer therapeutics market value in 2021 was USD2024.33 million, which is expected to grow further with a CAGR of 7.22% during the forecast period, 2023-2027, to achieve the market value of USD3126.26 million by 2027F. This impressive growth of the market can be attributed to the advancing healthcare industry, majorly the therapeutics sector for cancer treatments. Increasing instances of cancer like head cancer, throat cancer further drive the growth of the global head and neck cancer therapeutics market in the upcoming five years. Additionally, the market is also bound to experience growth due to advancements in the pharmaceutical industry. Precision medicine is highly implemented when cancer therapeutics are involved. The popularity of precision medicine, along with its specificity toward the cancer treatment of the respective patient being based on the type of cancer along with genetic information from the patient, enhances the success rates of the procedure, therefore, supporting the growth of the global head and neck cancer therapeutics market in the next five years. Increased consumption of tobacco and tobacco-based products, rapidly increasing smoking habits, and alcohol consumption among the population is also contributing to the increasing cases of throat cancer, which leads to the growth of the global head and neck cancer therapeutics market in the future five years.

The global head and neck cancer therapeutics market is majorly segmented by type, end user, regional distribution, and competition. By type, the market is differentiated into diagnostic methods and treatment type, where segments of the treatment type market are further analyzed by disease indication, route of administration, and therapeutic class. Diagnostic methods are forecast to dominate the market by holding the largest revenue shares of the market in the upcoming five years due to increasing demand for the early and efficient diagnosis of patients suffering from cancer. Treatment for the early stages of cancer is rather feasible and has a higher success rate; therefore, the demand for diagnosing cancer at its early stage drives the growth of the segment along with the growth of the global head and neck cancer therapeutics market in the next five years.

Treatment type segment is forecast to advance in the next five years and account for a share of over 41% in 2027 on the grounds of increasing advancement in the pharmaceutical and therapeutic sector. Surging demand for effective treatment for growing instances of cancer further aids the market growth.

Major companies in the global head and neck cancer therapeutics market are Eli Lilly and Company, Bristol Myers Squibb Company, Sanofi S.A., Merck & Co., Inc., Pfizer Inc, AbbVie Inc., Bayer AG, F. Hoffmann-La Roche Ltd., Fresenius Medical Care AG & Co. KGaA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Limited, AstraZeneca Plc., Astellas Pharma Inc., AB Science SA, Boston Biomedical, Inc., among others.

Years considered for this report:

Historical Years: 2017- 2020

Base Year: 2021

Estimated Year: 2022

Forecast Period: 2023 - 2027

Objective of the Study:

  • To analyze the market size of global head and neck cancer therapeutics market from 2017 to 2020.
  • To estimate and forecast the market size of global head and neck cancer therapeutics market from 2021 to 2022 and growth rate until 2027.
  • To classify and forecast global head and neck cancer therapeutics market based on type, end user, regional distribution, and competitional landscape.
  • To identify dominant region or segment in the global head and neck cancer therapeutics market.
  • To identify drivers and challenges for global head and neck cancer therapeutics market.
  • To examine competitive developments such as expansions, new product & service launches, mergers & acquisitions, etc., in global head and neck cancer therapeutics market.
  • To identify and analyze the profile of leading players operating in global head and neck cancer therapeutics market.
  • To identify key sustainable strategies adopted by market players in global head and neck cancer therapeutics market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers & service providers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers & service providers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers & service providers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global head and neck cancer therapeutics market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these products & services and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Manufacturers & service providers, suppliers
  • Distributors and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to head and neck cancer therapeutics
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, service providers, suppliers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global head and neck cancer therapeutics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Head and Neck Cancer Therapeutics Market, By Type:

Diagnostic Methods

  • Biopsy
  • Imaging
  • Endoscopy
  • Others

Treatment Type

  • Surgery
  • Radiation Therapy
  • Chemotherapy
  • Immunotherapy
  • Targeted Therapy
  • Head and Neck Cancer Therapeutics Market, By Treatment Type, By Disease Indication:

Lip and Oral Cavity Cancer

Laryngeal Cancer

Oropharyngeal Cancer

Salivary Gland Cancer

Nasopharyngeal Cancer

Hypopharyngeal Cancer

  • Head and Neck Cancer Therapeutics Market, By Treatment Type, By Route of Administration:

Injectable

Oral

  • Head and Neck Cancer Therapeutics Market, By Treatment Type, By Therapeutic Class:

PD Inhibitors

EGFR Inhibitors

Microtubule Inhibitors

  • Head and Neck Cancer Therapeutics Market, By End User:

Hospitals

Specialty Clinics

Ambulatory Surgical Centers

Others

  • Head and Neck Cancer Therapeutics Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain

Asia Pacific

  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Singapore

South America

  • Brazil
  • Argentina
  • Colombia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global head and neck cancer therapeutics market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

  • 4.1. Brand Awareness
  • 4.2. Preferred Diagnostic Method
  • 4.3. Preferred Treatment Type
  • 4.4. Preferred Route of Administration

5. Global Head and Neck Cancer Therapeutics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Diagnostic Methods v/s Treatment Type)
      • 5.2.1.1. By Diagnostic Methods (Biopsy, Imaging, Endoscopy, Others)
      • 5.2.1.2. By Treatment Type (Surgery, Radiation Therapy, Chemotherapy, Immunotherapy, Targeted Therapy)
        • 5.2.1.2.1. By Disease Indication (Lip and Oral Cavity Cancer, Laryngeal Cancer, Oropharyngeal Cancer, Salivary Gland Cancer, Nasopharyngeal Cancer, Hypopharyngeal Cancer)
        • 5.2.1.2.2. By Route of Administration (Injectable, Oral)
        • 5.2.1.2.3. By Therapeutic Class (PD Inhibitors, EGFR Inhibitors, Microtubule Inhibitors)
      • 5.2.1.3. By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others)
    • 5.2.2. By Region
    • 5.2.3. By Company (2021)
  • 5.3. Product Market Map

6. North America Head and Neck Cancer Therapeutics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
      • 6.2.1.1. By Diagnostic Methods
      • 6.2.1.2. By Treatment Type
        • 6.2.1.2.1. By Disease Indication
        • 6.2.1.2.2. By Route of Administration
        • 6.2.1.2.3. By Therapeutic Class
      • 6.2.1.3. By End User
    • 6.2.2. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Head and Neck Cancer Therapeutics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.1.1. By Diagnostic Methods
        • 6.3.1.2.1.2. By Treatment Type
        • 6.3.1.2.1.2.1. By Disease Indication
        • 6.3.1.2.1.2.2. By Route of Administration
        • 6.3.1.2.1.2.3. By Therapeutic Class
        • 6.3.1.2.2. By End User
    • 6.3.2. Canada Head and Neck Cancer Therapeutics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.1.1. By Diagnostic Methods
        • 6.3.2.2.1.2. By Treatment Type
        • 6.3.2.2.1.2.1. By Disease Indication
        • 6.3.2.2.1.2.2. By Route of Administration
        • 6.3.2.2.1.2.3. By Therapeutic Class
        • 6.3.2.2.2. By End User
    • 6.3.3. Mexico Head and Neck Cancer Therapeutics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.1.1. By Diagnostic Methods
        • 6.3.3.2.1.2. By Treatment Type
        • 6.3.3.2.1.2.1. By Disease Indication
        • 6.3.3.2.1.2.2. By Route of Administration
        • 6.3.3.2.1.2.3. By Therapeutic Class
        • 6.3.3.2.2. By End User

7. Europe Head and Neck Cancer Therapeutics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
      • 7.2.1.1. By Diagnostic Methods
      • 7.2.1.2. By Treatment Type
        • 7.2.1.2.1. By Disease Indication
        • 7.2.1.2.2. By Route of Administration
        • 7.2.1.2.3. By Therapeutic Class
      • 7.2.1.3. By End User
    • 7.2.2. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Head and Neck Cancer Therapeutics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.1.1. By Diagnostic Methods
        • 7.3.1.2.1.2. By Treatment Type
        • 7.3.1.2.1.2.1. By Disease Indication
        • 7.3.1.2.1.2.2. By Route of Administration
        • 7.3.1.2.1.2.3. By Therapeutic Class
        • 7.3.1.2.2. By End User
    • 7.3.2. Germany Head and Neck Cancer Therapeutics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.1.1. By Diagnostic Methods
        • 7.3.2.2.1.2. By Treatment Type
        • 7.3.2.2.1.2.1. By Disease Indication
        • 7.3.2.2.1.2.2. By Route of Administration
        • 7.3.2.2.1.2.3. By Therapeutic Class
        • 7.3.2.2.2. By End User
    • 7.3.3. United Kingdom Head and Neck Cancer Therapeutics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.1.1. By Diagnostic Methods
        • 7.3.3.2.1.2. By Treatment Type
        • 7.3.3.2.1.2.1. By Disease Indication
        • 7.3.3.2.1.2.2. By Route of Administration
        • 7.3.3.2.1.2.3. By Therapeutic Class
        • 7.3.3.2.2. By End User
    • 7.3.4. Italy Head and Neck Cancer Therapeutics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.1.1. By Diagnostic Methods
        • 7.3.4.2.1.2. By Treatment Type
        • 7.3.4.2.1.2.1. By Disease Indication
        • 7.3.4.2.1.2.2. By Route of Administration
        • 7.3.4.2.1.2.3. By Therapeutic Class
        • 7.3.4.2.2. By End User
    • 7.3.5. Spain Head and Neck Cancer Therapeutics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.1.1. By Diagnostic Methods
        • 7.3.5.2.1.2. By Treatment Type
        • 7.3.5.2.1.2.1. By Disease Indication
        • 7.3.5.2.1.2.2. By Route of Administration
        • 7.3.5.2.1.2.3. By Therapeutic Class
        • 7.3.5.2.2. By End User

8. Asia Pacific Head and Neck Cancer Therapeutics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
      • 8.2.1.1. By Diagnostic Methods
      • 8.2.1.2. By Treatment Type
        • 8.2.1.2.1. By Disease Indication
        • 8.2.1.2.2. By Route of Administration
        • 8.2.1.2.3. By Therapeutic Class
      • 8.2.1.3. By End User
    • 8.2.2. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Head and Neck Cancer Therapeutics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.1.1. By Diagnostic Methods
        • 8.3.1.2.1.2. By Treatment Type
        • 8.3.1.2.1.2.1. By Disease Indication
        • 8.3.1.2.1.2.2. By Route of Administration
        • 8.3.1.2.1.2.3. By Therapeutic Class
        • 8.3.1.2.2. By End User
    • 8.3.2. India Head and Neck Cancer Therapeutics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.1.1. By Diagnostic Methods
        • 8.3.2.2.1.2. By Treatment Type
        • 8.3.2.2.1.2.1. By Disease Indication
        • 8.3.2.2.1.2.2. By Route of Administration
        • 8.3.2.2.1.2.3. By Therapeutic Class
        • 8.3.2.2.2. By End User
    • 8.3.3. Japan Head and Neck Cancer Therapeutics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.1.1. By Diagnostic Methods
        • 8.3.3.2.1.2. By Treatment Type
        • 8.3.3.2.1.2.1. By Disease Indication
        • 8.3.3.2.1.2.2. By Route of Administration
        • 8.3.3.2.1.2.3. By Therapeutic Class
        • 8.3.3.2.2. By End User
    • 8.3.4. Australia Head and Neck Cancer Therapeutics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.1.1. By Diagnostic Methods
        • 8.3.4.2.1.2. By Treatment Type
        • 8.3.4.2.1.2.1. By Disease Indication
        • 8.3.4.2.1.2.2. By Route of Administration
        • 8.3.4.2.1.2.3. By Therapeutic Class
        • 8.3.4.2.2. By End User
    • 8.3.5. South Korea Head and Neck Cancer Therapeutics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.1.1. By Diagnostic Methods
        • 8.3.5.2.1.2. By Treatment Type
        • 8.3.5.2.1.2.1. By Disease Indication
        • 8.3.5.2.1.2.2. By Route of Administration
        • 8.3.5.2.1.2.3. By Therapeutic Class
        • 8.3.5.2.2. By End User
    • 8.3.6. Singapore Head and Neck Cancer Therapeutics Market Outlook
      • 8.3.6.1. Market Size & Forecast
        • 8.3.6.1.1. By Value
      • 8.3.6.2. Market Share & Forecast
        • 8.3.6.2.1. By Type
        • 8.3.6.2.1.1. By Diagnostic Methods
        • 8.3.6.2.1.2. By Treatment Type
        • 8.3.6.2.1.2.1. By Disease Indication
        • 8.3.6.2.1.2.2. By Route of Administration
        • 8.3.6.2.1.2.3. By Therapeutic Class
        • 8.3.6.2.2. By End User

9. South America Head and Neck Cancer Therapeutics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
      • 9.2.1.1. By Diagnostic Methods
      • 9.2.1.2. By Treatment Type
        • 9.2.1.2.1. By Disease Indication
        • 9.2.1.2.2. By Route of Administration
        • 9.2.1.2.3. By Therapeutic Class
      • 9.2.1.3. By End User
    • 9.2.2. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Head and Neck Cancer Therapeutics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.1.1. By Diagnostic Methods
        • 9.3.1.2.1.2. By Treatment Type
        • 9.3.1.2.1.2.1. By Disease Indication
        • 9.3.1.2.1.2.2. By Route of Administration
        • 9.3.1.2.1.2.3. By Therapeutic Class
        • 9.3.1.2.2. By End User
    • 9.3.2. Argentina Head and Neck Cancer Therapeutics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.1.1. By Diagnostic Methods
        • 9.3.2.2.1.2. By Treatment Type
        • 9.3.2.2.1.2.1. By Disease Indication
        • 9.3.2.2.1.2.2. By Route of Administration
        • 9.3.2.2.1.2.3. By Therapeutic Class
        • 9.3.2.2.2. By End User
    • 9.3.3. Colombia Head and Neck Cancer Therapeutics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.1.1. By Diagnostic Methods
        • 9.3.3.2.1.2. By Treatment Type
        • 9.3.3.2.1.2.1. By Disease Indication
        • 9.3.3.2.1.2.2. By Route of Administration
        • 9.3.3.2.1.2.3. By Therapeutic Class
        • 9.3.3.2.2. By End User

10. Middle East and Africa Head and Neck Cancer Therapeutics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
      • 10.2.1.1. By Diagnostic Methods
      • 10.2.1.2. By Treatment Type
        • 10.2.1.2.1. By Disease Indication
        • 10.2.1.2.2. By Route of Administration
        • 10.2.1.2.3. By Therapeutic Class
      • 10.2.1.3. By End User
    • 10.2.2. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Head and Neck Cancer Therapeutics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.1.1. By Diagnostic Methods
        • 10.3.1.2.1.2. By Treatment Type
        • 10.3.1.2.1.2.1. By Disease Indication
        • 10.3.1.2.1.2.2. By Route of Administration
        • 10.3.1.2.1.2.3. By Therapeutic Class
        • 10.3.1.2.2. By End User
    • 10.3.2. Saudi Arabia Head and Neck Cancer Therapeutics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.1.1. By Diagnostic Methods
        • 10.3.2.2.1.2. By Treatment Type
        • 10.3.2.2.1.2.1. By Disease Indication
        • 10.3.2.2.1.2.2. By Route of Administration
        • 10.3.2.2.1.2.3. By Therapeutic Class
        • 10.3.2.2.2. By End User
    • 10.3.3. UAE Head and Neck Cancer Therapeutics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.1.1. By Diagnostic Methods
        • 10.3.3.2.1.2. By Treatment Type
        • 10.3.3.2.1.2.1. By Disease Indication
        • 10.3.3.2.1.2.2. By Route of Administration
        • 10.3.3.2.1.2.3. By Therapeutic Class
        • 10.3.3.2.2. By End User

11. Clinical Trial Analysis

12. Impact of COVID-19 on Global Head and Neck Cancer Therapeutics Market

13. Market Dynamics

  • 13.1. Drivers
  • 13.2. Challenges

14. Market Trends & Developments

15. Competitive Landscape

  • 15.1. Competition Outlook
  • 15.2. Players Profiled
    • 15.2.1. Eli Lilly and Company
    • 15.2.2. Bristol Myers Squibb Company
    • 15.2.3. Sanofi S.A.
    • 15.2.4. Merck & Co., Inc.
    • 15.2.5. Pfizer Inc
    • 15.2.6. AbbVie Inc.
    • 15.2.7. Bayer AG
    • 15.2.8. F. Hoffmann-La Roche Ltd.
    • 15.2.9. Fresenius Medical Care AG & Co. KGaA
    • 15.2.10. Sun Pharmaceutical Industries Ltd.
    • 15.2.11. Teva Pharmaceutical Industries Limited
    • 15.2.12. AstraZeneca Plc.
    • 15.2.13. Astellas Pharma Inc.
    • 15.2.14. AB Science SA
    • 15.2.15. Boston Biomedical, Inc.

16. Strategic Recommendations

List of Figures

  • Figure 1: Global Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2017-2027F
  • Figure 2: Global Head and Neck Cancer Therapeutics Market Share, By Type, By Value, 2017-2027F
  • Figure 3: Global Head and Neck Cancer Therapeutics Market Share, By Type, By Diagnostic Methods, By Value, 2017-2027F
  • Figure 4: Global Head and Neck Cancer Therapeutics Market Share, By Type, By Treatment Type, By Value, 2017-2027F
  • Figure 5: Global Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Disease Indication, By Value, 2017-2027F
  • Figure 6: Global Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Route of Administration, By Value, 2017-2027F
  • Figure 7: Global Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Therapeutic Class, By Value, 2017-2027F
  • Figure 8: Global Head and Neck Cancer Therapeutics Market Share, By End User, By Value, 2017-2027F
  • Figure 9: Global Head and Neck Cancer Therapeutics Market Share, By Region, By Value, 2017-2027F
  • Figure 10: Global Head and Neck Cancer Therapeutics Market Share, By Company, By Value, 2021
  • Figure 11: Global Head and Neck Cancer Therapeutics Market Map, By Type, Market Size (USD Million) & Growth Rate (%), 2021
  • Figure 12: Global Head and Neck Cancer Therapeutics Market Map, By Type, By Diagnostic Methods, Market Size (USD Million) & Growth Rate (%), 2021
  • Figure 13: Global Head and Neck Cancer Therapeutics Market Map, By Type, By Treatment Type, Market Size (USD Million) & Growth Rate (%), 2021
  • Figure 14: Global Head and Neck Cancer Therapeutics Market Map, By Treatment Type, By Disease Indication, Market Size (USD Million) & Growth Rate (%), 2021
  • Figure 15: Global Head and Neck Cancer Therapeutics Market Map, By Treatment Type, By Route of Administration, Market Size (USD Million) & Growth Rate (%), 2021
  • Figure 16: Global Head and Neck Cancer Therapeutics Market Map, By Treatment Type, By Therapeutic Class, Market Size (USD Million) & Growth Rate (%), 2021
  • Figure 17: Global Head and Neck Cancer Therapeutics Market Map, By Treatment Type, By End User, Market Size (USD Million) & Growth Rate (%), 2021
  • Figure 18: Global Head and Neck Cancer Therapeutics Market Map, By Region, Market Size (USD Million) & Growth Rate (%), 2021
  • Figure 19: North America Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2017-2027F
  • Figure 20: North America Head and Neck Cancer Therapeutics Market Share, By Type, By Value, 2017-2027F
  • Figure 21: North America Head and Neck Cancer Therapeutics Market Share, By Type, By Diagnostic Methods, By Value, 2017-2027F
  • Figure 22: North America Head and Neck Cancer Therapeutics Market Share, By Type, By Treatment Type, By Value, 2017-2027F
  • Figure 23: North America Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Disease Indication, By Value, 2017-2027F
  • Figure 24: North America Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Route of Administration, By Value, 2017-2027F
  • Figure 25: North America Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Therapeutic Class, By Value, 2017-2027F
  • Figure 26: North America Head and Neck Cancer Therapeutics Market Share, By End User, By Value, 2017-2027F
  • Figure 27: North America Head and Neck Cancer Therapeutics Market Share, By Country, By Value, 2017-2027F
  • Figure 28: United States Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2017-2027F
  • Figure 29: United States Head and Neck Cancer Therapeutics Market Share, By Type, By Value, 2017-2027F
  • Figure 30: United States Head and Neck Cancer Therapeutics Market Share, By Type, By Diagnostic Methods, By Value, 2017-2027F
  • Figure 31: United States Head and Neck Cancer Therapeutics Market Share, By Type, By Treatment Type, By Value, 2017-2027F
  • Figure 32: United States Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Disease Indication, By Value, 2017-2027F
  • Figure 33: United States Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Route of Administration, By Value, 2017-2027F
  • Figure 34: United States Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Therapeutic Class, By Value, 2017-2027F
  • Figure 35: United States Head and Neck Cancer Therapeutics Market Share, By End User, By Value, 2017-2027F
  • Figure 36: Canada Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2017-2027F
  • Figure 37: Canada Head and Neck Cancer Therapeutics Market Share, By Type, By Value, 2017-2027F
  • Figure 38: Canada Head and Neck Cancer Therapeutics Market Share, By Type, By Diagnostic Methods, By Value, 2017-2027F
  • Figure 39: Canada Head and Neck Cancer Therapeutics Market Share, By Type, By Treatment Type, By Value, 2017-2027F
  • Figure 40: Canada Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Disease Indication, By Value, 2017-2027F
  • Figure 41: Canada Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Route of Administration, By Value, 2017-2027F
  • Figure 42: Canada Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Therapeutic Class, By Value, 2017-2027F
  • Figure 43: Canada Head and Neck Cancer Therapeutics Market Share, By End User, By Value, 2017-2027F
  • Figure 44: Mexico Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2017-2027F
  • Figure 45: Mexico Head and Neck Cancer Therapeutics Market Share, By Type, By Value, 2017-2027F
  • Figure 46: Mexico Head and Neck Cancer Therapeutics Market Share, By Type, By Diagnostic Methods, By Value, 2017-2027F
  • Figure 47: Mexico Head and Neck Cancer Therapeutics Market Share, By Type, By Treatment Type, By Value, 2017-2027F
  • Figure 48: Mexico Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Disease Indication, By Value, 2017-2027F
  • Figure 49: Mexico Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Route of Administration, By Value, 2017-2027F
  • Figure 50: Mexico Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Therapeutic Class, By Value, 2017-2027F
  • Figure 51: Mexico Head and Neck Cancer Therapeutics Market Share, By End User, By Value, 2017-2027F
  • Figure 52: Europe Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2017-2027F
  • Figure 53: Europe Head and Neck Cancer Therapeutics Market Share, By Type, By Value, 2017-2027F
  • Figure 54: Europe Head and Neck Cancer Therapeutics Market Share, By Type, By Diagnostic Methods, By Value, 2017-2027F
  • Figure 55: Europe Head and Neck Cancer Therapeutics Market Share, By Type, By Treatment Type, By Value, 2017-2027F
  • Figure 56: Europe Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Disease Indication, By Value, 2017-2027F
  • Figure 57: Europe Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Route of Administration, By Value, 2017-2027F
  • Figure 58: Europe Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Therapeutic Class, By Value, 2017-2027F
  • Figure 59: Europe Head and Neck Cancer Therapeutics Market Share, By End User, By Value, 2017-2027F
  • Figure 60: Europe Head and Neck Cancer Therapeutics Market Share, By Country, By Value, 2017-2027F
  • Figure 61: France Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2017-2027F
  • Figure 62: France Head and Neck Cancer Therapeutics Market Share, By Type, By Value, 2017-2027F
  • Figure 63: France Head and Neck Cancer Therapeutics Market Share, By Type, By Diagnostic Methods, By Value, 2017-2027F
  • Figure 64: France Head and Neck Cancer Therapeutics Market Share, By Type, By Treatment Type, By Value, 2017-2027F
  • Figure 65: France Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Disease Indication, By Value, 2017-2027F
  • Figure 66: France Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Route of Administration, By Value, 2017-2027F
  • Figure 67: France Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Therapeutic Class, By Value, 2017-2027F
  • Figure 68: France Head and Neck Cancer Therapeutics Market Share, By End User, By Value, 2017-2027F
  • Figure 69: Germany Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2017-2027F
  • Figure 70: Germany Head and Neck Cancer Therapeutics Market Share, By Type, By Value, 2017-2027F
  • Figure 71: Germany Head and Neck Cancer Therapeutics Market Share, By Type, By Diagnostic Methods, By Value, 2017-2027F
  • Figure 72: Germany Head and Neck Cancer Therapeutics Market Share, By Type, By Treatment Type, By Value, 2017-2027F
  • Figure 73: Germany Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Disease Indication, By Value, 2017-2027F
  • Figure 74: Germany Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Route of Administration, By Value, 2017-2027F
  • Figure 75: Germany Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Therapeutic Class, By Value, 2017-2027F
  • Figure 76: Germany Head and Neck Cancer Therapeutics Market Share, By End User, By Value, 2017-2027F
  • Figure 77: United Kingdom Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2017-2027F
  • Figure 78: United Kingdom Head and Neck Cancer Therapeutics Market Share, By Type, By Value, 2017-2027F
  • Figure 79: United Kingdom Head and Neck Cancer Therapeutics Market Share, By Type, By Diagnostic Methods, By Value, 2017-2027F
  • Figure 80: United Kingdom Head and Neck Cancer Therapeutics Market Share, By Type, By Treatment Type, By Value, 2017-2027F
  • Figure 81: United Kingdom Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Disease Indication, By Value, 2017-2027F
  • Figure 82: United Kingdom Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Route of Administration, By Value, 2017-2027F
  • Figure 83: United Kingdom Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Therapeutic Class, By Value, 2017-2027F
  • Figure 84: United Kingdom Head and Neck Cancer Therapeutics Market Share, By End User, By Value, 2017-2027F
  • Figure 85: Italy Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2017-2027F
  • Figure 86: Italy Head and Neck Cancer Therapeutics Market Share, By Type, By Value, 2017-2027F
  • Figure 87: Italy Head and Neck Cancer Therapeutics Market Share, By Type, By Diagnostic Methods, By Value, 2017-2027F
  • Figure 88: Italy Head and Neck Cancer Therapeutics Market Share, By Type, By Treatment Type, By Value, 2017-2027F
  • Figure 89: Italy Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Disease Indication, By Value, 2017-2027F
  • Figure 90: Italy Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Route of Administration, By Value, 2017-2027F
  • Figure 91: Italy Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Therapeutic Class, By Value, 2017-2027F
  • Figure 92: Italy Head and Neck Cancer Therapeutics Market Share, By End User, By Value, 2017-2027F
  • Figure 93: Spain Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2017-2027F
  • Figure 94: Spain Head and Neck Cancer Therapeutics Market Share, By Type, By Value, 2017-2027F
  • Figure 95: Spain Head and Neck Cancer Therapeutics Market Share, By Type, By Diagnostic Methods, By Value, 2017-2027F
  • Figure 96: Spain Head and Neck Cancer Therapeutics Market Share, By Type, By Treatment Type, By Value, 2017-2027F
  • Figure 97: Spain Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Disease Indication, By Value, 2017-2027F
  • Figure 98: Spain Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Route of Administration, By Value, 2017-2027F
  • Figure 99: Spain Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Therapeutic Class, By Value, 2017-2027F
  • Figure 100: Spain Head and Neck Cancer Therapeutics Market Share, By End User, By Value, 2017-2027F
  • Figure 101: Asia Pacific Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2017-2027F
  • Figure 102: Asia Pacific Head and Neck Cancer Therapeutics Market Share, By Type, By Value, 2017-2027F
  • Figure 103: Asia Pacific Head and Neck Cancer Therapeutics Market Share, By Type, By Diagnostic Methods, By Value, 2017-2027F
  • Figure 104: Asia Pacific Head and Neck Cancer Therapeutics Market Share, By Type, By Treatment Type, By Value, 2017-2027F
  • Figure 105: Asia Pacific Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Disease Indication, By Value, 2017-2027F
  • Figure 106: Asia Pacific Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Route of Administration, By Value, 2017-2027F
  • Figure 107: Asia Pacific Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Therapeutic Class, By Value, 2017-2027F
  • Figure 108: Asia Pacific Head and Neck Cancer Therapeutics Market Share, By End User, By Value, 2017-2027F
  • Figure 109: Asia Pacific Head and Neck Cancer Therapeutics Market Share, By Country, By Value, 2017-2027F
  • Figure 110: China Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2017-2027F
  • Figure 111: China Head and Neck Cancer Therapeutics Market Share, By Type, By Value, 2017-2027F
  • Figure 112: China Head and Neck Cancer Therapeutics Market Share, By Type, By Diagnostic Methods, By Value, 2017-2027F
  • Figure 113: China Head and Neck Cancer Therapeutics Market Share, By Type, By Treatment Type, By Value, 2017-2027F
  • Figure 114: China Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Disease Indication, By Value, 2017-2027F
  • Figure 115: China Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Route of Administration, By Value, 2017-2027F
  • Figure 116: China Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Therapeutic Class, By Value, 2017-2027F
  • Figure 117: China Head and Neck Cancer Therapeutics Market Share, By End User, By Value, 2017-2027F
  • Figure 118: India Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2017-2027F
  • Figure 119: India Head and Neck Cancer Therapeutics Market Share, By Type, By Value, 2017-2027F
  • Figure 120: India Head and Neck Cancer Therapeutics Market Share, By Type, By Diagnostic Methods, By Value, 2017-2027F
  • Figure 121: India Head and Neck Cancer Therapeutics Market Share, By Type, By Treatment Type, By Value, 2017-2027F
  • Figure 122: India Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Disease Indication, By Value, 2017-2027F
  • Figure 123: India Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Route of Administration, By Value, 2017-2027F
  • Figure 124: India Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Therapeutic Class, By Value, 2017-2027F
  • Figure 125: India Head and Neck Cancer Therapeutics Market Share, By End User, By Value, 2017-2027F
  • Figure 126: Japan Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2017-2027F
  • Figure 127: Japan Head and Neck Cancer Therapeutics Market Share, By Type, By Value, 2017-2027F
  • Figure 128: Japan Head and Neck Cancer Therapeutics Market Share, By Type, By Diagnostic Methods, By Value, 2017-2027F
  • Figure 129: Japan Head and Neck Cancer Therapeutics Market Share, By Type, By Treatment Type, By Value, 2017-2027F
  • Figure 130: Japan Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Disease Indication, By Value, 2017-2027F
  • Figure 131: Japan Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Route of Administration, By Value, 2017-2027F
  • Figure 132: Japan Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Therapeutic Class, By Value, 2017-2027F
  • Figure 133: Japan Head and Neck Cancer Therapeutics Market Share, By End User, By Value, 2017-2027F
  • Figure 134: Australia Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2017-2027F
  • Figure 135: Australia Head and Neck Cancer Therapeutics Market Share, By Type, By Value, 2017-2027F
  • Figure 136: Australia Head and Neck Cancer Therapeutics Market Share, By Type, By Diagnostic Methods, By Value, 2017-2027F
  • Figure 137: Australia Head and Neck Cancer Therapeutics Market Share, By Type, By Treatment Type, By Value, 2017-2027F
  • Figure 138: Australia Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Disease Indication, By Value, 2017-2027F
  • Figure 139: Australia Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Route of Administration, By Value, 2017-2027F
  • Figure 140: Australia Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Therapeutic Class, By Value, 2017-2027F
  • Figure 141: Australia Head and Neck Cancer Therapeutics Market Share, By End User, By Value, 2017-2027F
  • Figure 142: South Korea Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2017-2027F
  • Figure 143: South Korea Head and Neck Cancer Therapeutics Market Share, By Type, By Value, 2017-2027F
  • Figure 144: South Korea Head and Neck Cancer Therapeutics Market Share, By Type, By Diagnostic Methods, By Value, 2017-2027F
  • Figure 145: South Korea Head and Neck Cancer Therapeutics Market Share, By Type, By Treatment Type, By Value, 2017-2027F
  • Figure 146: South Korea Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Disease Indication, By Value, 2017-2027F
  • Figure 147: South Korea Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Route of Administration, By Value, 2017-2027F
  • Figure 148: South Korea Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Therapeutic Class, By Value, 2017-2027F
  • Figure 149: South Korea Head and Neck Cancer Therapeutics Market Share, By End User, By Value, 2017-2027F
  • Figure 150: Singapore Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2017-2027F
  • Figure 151: Singapore Head and Neck Cancer Therapeutics Market Share, By Type, By Value, 2017-2027F
  • Figure 152: Singapore Head and Neck Cancer Therapeutics Market Share, By Type, By Diagnostic Methods, By Value, 2017-2027F
  • Figure 153: Singapore Head and Neck Cancer Therapeutics Market Share, By Type, By Treatment Type, By Value, 2017-2027F
  • Figure 154: Singapore Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Disease Indication, By Value, 2017-2027F
  • Figure 155: Singapore Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Route of Administration, By Value, 2017-2027F
  • Figure 156: Singapore Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Therapeutic Class, By Value, 2017-2027F
  • Figure 157: Singapore Head and Neck Cancer Therapeutics Market Share, By End User, By Value, 2017-2027F
  • Figure 158: South America Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2017-2027F
  • Figure 159: South America Head and Neck Cancer Therapeutics Market Share, By Type, By Value, 2017-2027F
  • Figure 160: South America Head and Neck Cancer Therapeutics Market Share, By Type, By Diagnostic Methods, By Value, 2017-2027F
  • Figure 161: South America Head and Neck Cancer Therapeutics Market Share, By Type, By Treatment Type, By Value, 2017-2027F
  • Figure 162: South America Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Disease Indication, By Value, 2017-2027F
  • Figure 163: South America Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Route of Administration, By Value, 2017-2027F
  • Figure 164: South America Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Therapeutic Class, By Value, 2017-2027F
  • Figure 165: South America Head and Neck Cancer Therapeutics Market Share, By End User, By Value, 2017-2027F
  • Figure 166: South America Head and Neck Cancer Therapeutics Market Share, By Country, By Value, 2017-2027F
  • Figure 167: Brazil Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2017-2027F
  • Figure 168: Brazil Head and Neck Cancer Therapeutics Market Share, By Type, By Value, 2017-2027F
  • Figure 169: Brazil Head and Neck Cancer Therapeutics Market Share, By Type, By Diagnostic Methods, By Value, 2017-2027F
  • Figure 170: Brazil Head and Neck Cancer Therapeutics Market Share, By Type, By Treatment Type, By Value, 2017-2027F
  • Figure 171: Brazil Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Disease Indication, By Value, 2017-2027F
  • Figure 172: Brazil Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Route of Administration, By Value, 2017-2027F
  • Figure 173: Brazil Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Therapeutic Class, By Value, 2017-2027F
  • Figure 174: Brazil Head and Neck Cancer Therapeutics Market Share, By End User, By Value, 2017-2027F
  • Figure 175: Argentina Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2017-2027F
  • Figure 176: Argentina Head and Neck Cancer Therapeutics Market Share, By Type, By Value, 2017-2027F
  • Figure 177: Argentina Head and Neck Cancer Therapeutics Market Share, By Type, By Diagnostic Methods, By Value, 2017-2027F
  • Figure 178: Argentina Head and Neck Cancer Therapeutics Market Share, By Type, By Treatment Type, By Value, 2017-2027F
  • Figure 179: Argentina Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Disease Indication, By Value, 2017-2027F
  • Figure 180: Argentina Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Route of Administration, By Value, 2017-2027F
  • Figure 181: Argentina Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Therapeutic Class, By Value, 2017-2027F
  • Figure 182: Argentina Head and Neck Cancer Therapeutics Market Share, By End User, By Value, 2017-2027F
  • Figure 183: Colombia Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2017-2027F
  • Figure 184: Colombia Head and Neck Cancer Therapeutics Market Share, By Type, By Value, 2017-2027F
  • Figure 185: Colombia Head and Neck Cancer Therapeutics Market Share, By Type, By Diagnostic Methods, By Value, 2017-2027F
  • Figure 186: Colombia Head and Neck Cancer Therapeutics Market Share, By Type, By Treatment Type, By Value, 2017-2027F
  • Figure 187: Colombia Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Disease Indication, By Value, 2017-2027F
  • Figure 188: Colombia Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Route of Administration, By Value, 2017-2027F
  • Figure 189: Colombia Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Therapeutic Class, By Value, 2017-2027F
  • Figure 190: Colombia Head and Neck Cancer Therapeutics Market Share, By End User, By Value, 2017-2027F
  • Figure 191: Middle East & Africa Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2017-2027F
  • Figure 192: Middle East & Africa Head and Neck Cancer Therapeutics Market Share, By Type, By Value, 2017-2027F
  • Figure 193: Middle East & Africa Head and Neck Cancer Therapeutics Market Share, By Type, By Diagnostic Methods, By Value, 2017-2027F
  • Figure 194: Middle East & Africa Head and Neck Cancer Therapeutics Market Share, By Type, By Treatment Type, By Value, 2017-2027F
  • Figure 195: Middle East & Africa Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Disease Indication, By Value, 2017-2027F
  • Figure 196: Middle East & Africa Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Route of Administration, By Value, 2017-2027F
  • Figure 197: Middle East & Africa Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Therapeutic Class, By Value, 2017-2027F
  • Figure 198: Middle East & Africa Head and Neck Cancer Therapeutics Market Share, By End User, By Value, 2017-2027F
  • Figure 199: Middle East & Africa Head and Neck Cancer Therapeutics Market Share, By Country, By Value, 2017-2027F
  • Figure 200: South Africa Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2017-2027F
  • Figure 201: South Africa Head and Neck Cancer Therapeutics Market Share, By Type, By Value, 2017-2027F
  • Figure 202: South Africa Head and Neck Cancer Therapeutics Market Share, By Type, By Diagnostic Methods, By Value, 2017-2027F
  • Figure 203: South Africa Head and Neck Cancer Therapeutics Market Share, By Type, By Treatment Type, By Value, 2017-2027F
  • Figure 204: South Africa Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Disease Indication, By Value, 2017-2027F
  • Figure 205: South Africa Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Route of Administration, By Value, 2017-2027F
  • Figure 206: South Africa Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Therapeutic Class, By Value, 2017-2027F
  • Figure 207: South Africa Head and Neck Cancer Therapeutics Market Share, By End User, By Value, 2017-2027F
  • Figure 208: Saudi Arabia Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2017-2027F
  • Figure 209: Saudi Arabia Head and Neck Cancer Therapeutics Market Share, By Type, By Value, 2017-2027F
  • Figure 210: Saudi Arabia Head and Neck Cancer Therapeutics Market Share, By Type, By Diagnostic Methods, By Value, 2017-2027F
  • Figure 211: Saudi Arabia Head and Neck Cancer Therapeutics Market Share, By Type, By Treatment Type, By Value, 2017-2027F
  • Figure 212: Saudi Arabia Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Disease Indication, By Value, 2017-2027F
  • Figure 213: Saudi Arabia Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Route of Administration, By Value, 2017-2027F
  • Figure 214: Saudi Arabia Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Therapeutic Class, By Value, 2017-2027F
  • Figure 215: Saudi Arabia Head and Neck Cancer Therapeutics Market Share, By End User, By Value, 2017-2027F
  • Figure 216: UAE Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2017-2027F
  • Figure 217: UAE Head and Neck Cancer Therapeutics Market Share, By Type, By Value, 2017-2027F
  • Figure 218: UAE Head and Neck Cancer Therapeutics Market Share, By Type, By Diagnostic Methods, By Value, 2017-2027F
  • Figure 219: UAE Head and Neck Cancer Therapeutics Market Share, By Type, By Treatment Type, By Value, 2017-2027F
  • Figure 220: UAE Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Disease Indication, By Value, 2017-2027F
  • Figure 221: UAE Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Route of Administration, By Value, 2017-2027F
  • Figure 222: UAE Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Therapeutic Class, By Value, 2017-2027F
  • Figure 223: UAE Head and Neck Cancer Therapeutics Market Share, By End User, By Value, 2017-2027F
  • Figure 224: Clinical Trials Studies on Head and Neck Cancer Therapeutics, 2017 and 2021

List of Tables

  • Table 1: Global Cancer Statistics, 2020
  • Table 2: Total Number of New Cancer Cases and Deaths Reported Globally, By Type, 2020
  • Table 3: North America Cancer Statistics, 2020
  • Table 4: Total Number of New Cancer Cases and Deaths Reported in North America, By Type, 2020
  • Table 5: Europe Cancer Statistics, 2020
  • Table 6: Total Number of New Cancer Cases and Deaths Reported in Europe, By Type, 2020
  • Table 7: Asia-Pacific Cancer Statistics, 2020
  • Table 8: Total Number of New Cancer Cases and Deaths Reported in Asia Pacific, By Type, 2020
  • Table 9: South America Cancer Statistics, 2020
  • Table 10: Total Number of New Cancer Cases and Deaths Reported in South America, By Type, 2020
  • Table 11: Middle East & Africa Cancer Statistics, 2020
  • Table 12: Total Number of New Cancer Cases and Deaths Reported in Middle East, By Type, 2020
  • Table 13: Clinical Trial Studies on Head and Neck Cancer Therapeutics, 2021